Farther Finance Advisors’s Nuvation Bio NUVB Stock Holding History

Farther Finance Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.5K	Buy	4,145 +1,962	+90%	+$9.59K	﹤0.01%	3856
2026 Q1	$9.85K	Sell	2,183 -1,051	-32%	-$5.86K	﹤0.01%	4124
2025 Q4	$29K	Buy	3,234 +1,176	+57%	+$7.29K	﹤0.01%	3181
2025 Q3	$7.62K	Buy	2,058 +186	+10%	+$507	﹤0.01%	3566
2025 Q2	$3.65K	Hold	1,872	–	–	﹤0.01%	3489
2025 Q1	$3.28K	Sell	1,872 -340	-15%	-$774	﹤0.01%	3211
2024 Q4	$5.88K	Hold	2,212	–	–	﹤0.01%	2598
2024 Q3	$5.07K	Hold	2,212	–	–	﹤0.01%	2637
2024 Q2	$6.99K	Buy	+2,212	New	+$6.75K	﹤0.01%	2238
2024 Q1	–	Sell	-10	Closed	-$15	–	3683
2023 Q4	$15	Buy	+10	New	+$13	﹤0.01%	3482

Other funds holding NUVB

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

FWP

Firethorn Wealth Partners Augusta, Georgia $310M AUM 23.22% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

SIC

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

Farther Finance Advisors's NUVB Position: Q2 2026 in Review

Farther Finance Advisors increased its Nuvation Bio (NUVB) stake by 90% in Q2 2026, buying an estimated $9.59K and bringing the position to 4,145 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3856.

Farther Finance Advisors first reported a position in NUVB in Q4 2023 and has held it in 10 quarters since. The position peaked at $29K in Q4 2025. 13 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

Farther Finance Advisors held 4,145 shares of Nuvation Bio worth $23.5K as of Q2 2026.
Farther Finance Advisors bought 1,962 Nuvation Bio shares in Q2 2026, an estimated $9.59K.
Nuvation Bio made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3856 holding.
Farther Finance Advisors first reported a position in Nuvation Bio in Q4 2023 and has held it in 10 quarters since.
Farther Finance Advisors's Nuvation Bio position peaked at $29K in Q4 2025.
13 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.